Aligos Therapeutics (ALGS) Shareholder's Equity (2019 - 2026)
Aligos Therapeutics (ALGS) Shareholder's Equity (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
502.95 Mn |
| 10 |
Aligos Therapeutics |
54.72 Mn |
-25.11 Mn |
- |
31.79 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
31.79 Mn |
| Dec 31, 2025 |
53.55 Mn |
| Sep 30, 2025 |
71.83 Mn |
| Jun 30, 2025 |
101.87 Mn |
| Mar 31, 2025 |
116.45 Mn |
| Dec 31, 2024 |
-28.97 Mn |
| Sep 30, 2024 |
50.10 Mn |
| Jun 30, 2024 |
67.23 Mn |
| Mar 31, 2024 |
59.80 Mn |
| Dec 31, 2023 |
92.08 Mn |
| Sep 30, 2023 |
54.82 Mn |
| Jun 30, 2023 |
69.64 Mn |
| Mar 31, 2023 |
84.75 Mn |
| Dec 31, 2022 |
103.90 Mn |
| Sep 30, 2022 |
122.01 Mn |
| Jun 30, 2022 |
136.98 Mn |
| Mar 31, 2022 |
152.89 Mn |
| Dec 31, 2021 |
184.73 Mn |
| Sep 30, 2021 |
217.01 Mn |
| Jun 30, 2021 |
168.88 Mn |
